| Both sides previous revisionPrevious revision | Both sides next revision |
combating_antibiotic_resistant_bacteria_biopharmaceutical_accelerator [2023/05/11 22:02]
liam | — (current) |
|---|
| ====== Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator ====== | |
| |
| {{ ::download_10_.png?200|}} | |
| |
| The **Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)** is a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria. | |
| |
| ===== History ===== | |
| |
| On February 18, 2020, CARB-X awarded a $16.9 million grant to [[pharmaceutical_companies:Lytica Therapeutics]] for a project to "develop antibacterial peptides with broad activity against multidrug-resistant bacteria."((Robinson, J., & Finnegan, A. (2020, April 18). //CARB-X funds Lytica Therapeutics to develop antibacterial peptides to treat drug-resistant infections in the lungs and other parts of the body.// CARB-X. http://archive.today/2021.08.08-003713/https://carb-x.org/carb-x-news/carb-x-funds-lytica-therapeutics-to-develop-antibacterial-peptides-to-treat-drug-resistant-infections-in-the-lungs-and-other-parts-of-the-body/)) ((Hounsell, S. (2021, August 6). //EXCLUSIVE: CDC Director Walensky’s Husband Received $5 Million in HHS Grants - and That’s Just the Start of It.// RedState. https://web.archive.org/web/20230110204450/https://redstate.com/scotthounsell/2021/08/06/exclusive-cdc-director-walenskys-husband-received-5-million-in-hhs-grants-and-thats-just-the-start-of-it-n421809)) | |
| |
| ===== Organization ===== | |
| |
| ==== Funding ==== | |
| |
| CARB-X is funded by the [[Bill & Melinda Gates Foundation]], [[Biomedical Advanced Research and Development Authority]] (BARDA), [[German Federal Ministry of Education and Research]], [[National Institute of Allergy and Infectious Diseases]] (NIAID), [[United Kingdom Department of Health and Social Care]] (through the [[Global Antimicrobial Resistance Innovation Fund]]), and the [[Wellcome Trust]].((//Funding Partners.// (2022). CARB-X. http://archive.today/2022.06.06-075157/https://carb-x.org/partners/funding-partners/)) | |
| |
| ==== Team ==== | |
| |
| ^ CARB-X Team ^^^ | |
| ^ Name ^ Affiliation ^ Notes ^ | |
| | [[Christopher Houchens]] | BARDA | - | | |
| | [[Mark Albrecht]] | BARDA | - | | |
| | [[Cameron Bess]] | BARDA | - | | |
| | [[Timothy Jinks]] | [[Wellcome Trust]] | - | | |
| | [[Torsten Geissler]] | [[German Federal Ministry of Education and Research]] | - | | |
| | [[Claudia Baumann]] | [[German Federal Ministry of Education and Research]] | - | | |
| | [[Dennis M. Dixon]] | [[National Institute of Allergy and Infectious Diseases]] | - | | |
| | [[Paul Eder]] | [[National Institute of Allergy and Infectious Diseases]] | - | | |
| | [[Nick Adkin]] | [[United Kingdom Department of Health and Social Care]] | - | | |
| | [[Keith Klugman]] | [[Bill & Melinda Gates Foundation]] | - | | |
| | [[Padmini Srikantiah]] | [[Bill & Melinda Gates Foundation]] | - | | |
| |
| ==== Global Accelerator Network ==== | |
| |
| CARB-X's Global Accelerator Network is composed of:((//Global Accelerator Network.// (2022). CARB-X. https://archive.ph/LXbx5)) | |
| |
| * [[California Life Sciences]] | |
| * [[Centre for Cellular and Molecular Platforms]] (C-CAMP) | |
| * [[Foundation for Innovative New Diagnostics]] (FIND) | |
| * [[German Center for Infectious Diseases]] (DZIF) | |
| * [[Institute for Life Sciences Entrepreneurship]] (ILSE) | |
| * [[RTI International]] | |
